Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients

Peng Zhao, Clara Effenberger, Saki Matsumoto, Takafumi Morisaki, Yu Ishii, Masayo Umebayashi, Hiroto Tanaka, Norihiro Koya, Shinichiro Nakagawa, Kenta Tsujimura, Yusuke Nakamura, Takashi Morisaki, Kazuma Kiyotani

Open source

DOI
10.3389/fimmu.2026.1829509
Published
2026-06-09
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1829509,
  title = {Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients},
  author = {Peng Zhao and Clara Effenberger and Saki Matsumoto and Takafumi Morisaki and Yu Ishii and Masayo Umebayashi and Hiroto Tanaka and Norihiro Koya and Shinichiro Nakagawa and Kenta Tsujimura and Yusuke Nakamura and Takashi Morisaki and Kazuma Kiyotani},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1829509},
  url = {https://doi.org/10.3389/fimmu.2026.1829509}
}

RIS

TY  - JOUR
TI  - Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients
AU  - Peng Zhao
AU  - Clara Effenberger
AU  - Saki Matsumoto
AU  - Takafumi Morisaki
AU  - Yu Ishii
AU  - Masayo Umebayashi
AU  - Hiroto Tanaka
AU  - Norihiro Koya
AU  - Shinichiro Nakagawa
AU  - Kenta Tsujimura
AU  - Yusuke Nakamura
AU  - Takashi Morisaki
AU  - Kazuma Kiyotani
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1829509
UR  - https://doi.org/10.3389/fimmu.2026.1829509
ER  - 

APA

Zhao, P., Effenberger, C., Matsumoto, S., Morisaki, T., Ishii, Y., Umebayashi, M., Tanaka, H., Koya, N., Nakagawa, S., Tsujimura, K., Nakamura, Y., Morisaki, T., & Kiyotani, K. (2026). Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1829509

Source records